On March 24, 2025, Oncology Institute Inc. entered into a Securities Purchase Agreement to sell 12,006,510 shares and warrants for approximately $16.5 million to support growth and working capital. Additionally, they exchanged $4.1 million in convertible notes for preferred stock and warrants, and filed amendments to their stock designations.